Cargando…
Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
OBJECTIVE: Ovarian hyperstimulation syndrome (OHSS) remains as a clinical problem for hyperresponder patients during controlled ovarian hyperstimulation and in vitro fertilization (COH-IVF) procedure. Herein, we aimed to evaluate the COH-IVF outcomes in hyperresponder patients managed with coasting...
Autores principales: | Yumuşak, Ömer Hamid, Kahyaoğlu, Serkan, Özgü Erdinç, Ayşe Seval, Yılmaz, Saynur, Engin Üstün, Yaprak, Yılmaz, Nafiye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558327/ https://www.ncbi.nlm.nih.gov/pubmed/28913010 http://dx.doi.org/10.4274/tjod.48751 |
Ejemplares similares
-
Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats
por: Ateş, Çağlayan, et al.
Publicado: (2023) -
Inflammatory Markers in Peripheral Blood Cells Cannot Predict Intrauterine Insemination Outcome: A Retrospective Cohort Study
por: Pekcan, Meryem Kuru, et al.
Publicado: (2021) -
There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein
por: Ozgu-Erdinc, A. Seval, et al.
Publicado: (2019) -
The Role of Inflammatory Hematological Markers in Predicting IVF Success
por: Ozgu-Erdinc, A Seval, et al.
Publicado: (2021) -
Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)